Skip to main content
Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
5.00
-0.12 (-2.34%)
At close: Apr 28, 2026, 4:00 PM EDT
5.10
+0.10 (2.00%)
After-hours: Apr 28, 2026, 7:20 PM EDT

Opus Genetics Revenue

In the year 2025, Opus Genetics had annual revenue of $14.20M with 29.15% growth. Opus Genetics had revenue of $3.87M in the quarter ending December 31, 2025, a decrease of -10.16%.

Revenue (ttm)
$14.20M
Revenue Growth
+29.15%
P/S Ratio
25.15
Revenue / Employee
$507,000
Employees
28
Market Cap
357.01M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202514.20M3.20M29.15%
Dec 31, 202410.99M-8.06M-42.30%
Dec 31, 202319.05M-20.80M-52.20%
Dec 31, 202239.85M39.26M6,665.70%
Dec 31, 2021589.00K--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 228.37M
Enanta Pharmaceuticals 66.98M
X4 Pharmaceuticals 35.11M
Surrozen 3.48M
Compass Therapeutics 850.00K
Silence Therapeutics 559.00K
YD Bio 510.36K
vTv Therapeutics 17.00K
Revenue Rankings

IRD News

More News